Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

May 2, 2018

Accelerator Life Science Partners launches Proniras

April 30, 2018

Researchers present gene therapy for methamphetamine-induced inflammation

April 27, 2018

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

April 19, 2018

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

April 19, 2018

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

April 19, 2018

Humanetics obtains NIAID grant to support development of BIO-300 as a medical countermeasure

April 13, 2018

FDA approves Leukine for H-ARS

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026